Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 10, 2012
WORD interviews Dr. Adam Walter about his abstract entitled, "Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the U.S. Medicare system". This video is part of a series of video interviews from WORDonCancer.org's coverage of the Society of Gynecologic Oncology's 43 Annual Meeting on Women's Cancer®